Hep Fall 2014 – Special Issue

Hep Fall 2014 – Special Issue

In this issue, you’ll meet activist Lucinda Porter. Scroll down to click on her story and to see what else is inside.

Also Available On:



Lucinda K. Porter, RN

Hep Hero

How one woman overcame hepatitis C and ended up helping others fight it, too.

From the Editor

Oriol R. Gutierrez

Eye of the Tiger

The potential for up to millions of Americans to benefit from the new hep C meds makes this one of the most exciting moments in modern medicin...

Treatment News

Sovaldi-Ledipasvir Pill Safe With Major HIV Meds

Gilead Sciences’ fixed-dose combination pill of Sovaldi (sofosbuvir) and the investigational ledipasvir, likely to receive FDA approval on Oct...

’3D’ Cures 99% to 100% of Genotype 1b

AbbVie’s so-called ’3D’ combo regimen ditched ribavirin and still cured 99 percent to 100 percent of study participants with genotype 1b of he...

Daclatasvir and Asunaprevir Cure Up to 87% of 1b

Bristol-Myers Squibb’s daclatasvir and asunaprevir cured 81 percent to 87 percent of people with genotype 1b of hepatitis C in a recent Phase...

Primary Care Docs Clueless About Hep C Drugs

About three out of four primary care physicians (PCPs) are unfamiliar with the new generation of hep C drugs which received U.S. Food and Drug...

Hep C Suppression Linked to Major Health Benefits

Suppressing the hep C viral load is associated with a diminished risk of liver disease and death.

Curing Hep C Lowers Central Nervous System Fatigue

Ridding the body of hep C reduces central fatigue, which is weakness originating in the central nervous system.


Hot topics